About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Tennessee | 18,951 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,951 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 961-980 of 18,951 trials

CompletedPantheris Atherectomy Treatment of In-Stent Restenosis In Lower Extremity ArteriesA prospective, non-randomized, international, multi-center study to evaluate the safety and effectiveness of the Pantheris OCT-Imaging System to perform atherectomy in In-Stent…NCT03192696·Jonesboro, Arkansas and 11 others CompletedDrug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative VolunteersThe purpose of this study is to measure the blood levels of amprenavir (APV) alone, APV combined with efavirenz (EFV), and APV/EFV combined with a third drug (nelfinavir \[NFV\]…NCT00005762·Palo Alto, California and 7 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

TerminatedPreliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight InfantsThis is a pilot study to collect preliminary data for a larger, multicenter clinical trial proposal.NCT03982342·Columbus, Ohio and 1 other

Active not recruitingStudy to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)Global, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and safety of furmonertinib (firmonertinib) at 2 dose levels (160 mg once daily \[QD\] and 240…NCT05607550·Daphne, Alabama and 207 others

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderThis study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.NCT00320268·Little Rock, Arkansas and 36 others

RecruitingJZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid TumorsThis Phase 1 first-in-human study will investigate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of JZP898 monotherapy as…NCT06108050·Encinitas, California and 9 others

TerminatedEfficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin LymphomasThe primary objective of this study is to evaluate the effect of the addition of idelalisib to rituximab on progression-free survival (PFS) in adults with previously treated…NCT01732913·Huntsville, Alabama and 102 others

CompletedA Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenThe main objective of this study is to assess safety and efficacy of elagolix compared to placebo in reducing heavy menstrual bleeding (HMB) associated with uterine fibroids in…NCT03886220·Birmingham, Alabama and 47 others

CompletedTreatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic LeukemiaA common and potentially debilitating late effect of childhood cancer treatment is neurocognitive impairment, frequently in the domain of executive dysfunction, which can limit…NCT02336282·Memphis, Tennessee

CompletedDevelopment of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me"This study addresses the intractable challenges of adverse birth outcomes, including preterm delivery and low birthweight, by proposing the development, implementation and…NCT02169024·Detroit, Michigan and 1 other

CompletedExamination of Sleep and Family Functioning in Pediatric Craniopharyngioma PatientsPediatric craniopharyngioma patients experience significant endocrine and sleep dysregulation difficulties.NCT03330080·Memphis, Tennessee

Active not recruitingA Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerThe purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given together for the treatment of colorectal cancer…NCT05217446·Phoenix, Arizona and 58 others

RecruitingEarly Use of Long-acting Tacrolimus in Lung Transplant RecipientsLung transplantation is a life-saving therapy for patients with advanced lung disease, however, necessitates the use of life-long immunosuppressive therapy for the prevention of…NCT04469842·Nashville, Tennessee

CompletedPhase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusPhase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.NCT06152042·North Miami Beach, Florida and 10 others

CompletedA Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaThis is a phase I study of temsirolimus (Torisel) combined with dexamethasone, cyclophosphamide and etoposide in patients with relapsed acute lymphoblastic leukemia (ALL)…NCT01614197·Los Angeles, California and 31 others

CompletedA Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightThis study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 different doses of NNC0519-0130.NCT06326060·Mesa, Arizona and 69 others

CompletedPharmacokinetics and Safety of Solithromycin in Adolescents and ChildrenPediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17NCT02268279·Little Rock, Arkansas and 33 others

CompletedMIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU CareThis will be the first large cohort study to define the epidemiology of and identify modifiable risk factors for long-term CI and functional deficits of ICU survivors.NCT00400062·Nashville, Tennessee and 2 others

RecruitingSafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaThe safety, tolerability, and antileukemic response of ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia will…NCT06001788·Gilbert, Arizona and 44 others

TerminatedA Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell CarcinomaThis is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining CDX-3379 and cetuximab.NCT03254927·Tucson, Arizona and 9 others

PreviousPage 49 of 948Next

Diabetes

in Tennessee

Heart Diseasein Tennessee